Loading...
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL
This phase 2 study was conducted to prospectively evaluate how clinical and biological factors correlate with outcome in patients with treatment-naive (TN) and relapsed (R) chronic lymphocytic leukemia (CLL) treated with lenalidomide and rituximab. Oral lenalidomide 10 mg was administered daily star...
Saved in:
| Published in: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517659/ https://ncbi.nlm.nih.gov/pubmed/31076409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019031336 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|